You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vasculopathy

Showing 1 - 25 of 417
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Smoking, Weak Association With Thrombophilia

Completed
  • Livedoid Vasculitis
  • Thrombophilia screening
  • Basel, Switzerland
  • +2 more
May 17, 2023

Coronary Allograft Vasculopathy (CAV) Trial (CardioFlux)

Not yet recruiting
  • Coronary Allograft Vasculopathy (CAV)
  • CardioFlux
  • (no location specified)
Feb 21, 2023

Microvascular Cardiac Allograft Vasculopathy Trial

Recruiting
  • Cardiac Allograft Vasculopathy
  • Echocardiography
  • +7 more
  • Berlin, Germany
    DHZC Deutsches Herzzentrum der Charité
Apr 12, 2023

Cardiac Allograft Vasculopathy Trial in Canada (ICA, PET)

Not yet recruiting
  • Cardiac Allograft Vasculopathy
  • ICA
  • PET
  • Calgary, Alberta, Canada
  • +4 more
Oct 12, 2023

CD34 + Stem Cells and Biological Markers of Angiogenesis in

Recruiting
  • Vasculopathy
  • Heart Transplant Failure
  • coronary CT angiography
  • Ljubljana, Slovenia
    Advanced Heart Failure and Transplantation Center, University Me
Aug 2, 2022

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • +2 more
  • Intravitreal aflibercept injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Dec 20, 2022

Cardiac Allograft Vasculopathy Trial in Seoul

Recruiting
  • Cardiac Allograft Vasculopathy
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 6, 2022

    Vasculopathy Trial (Atorvastatin 80 Mg Oral Tablet)

    Not yet recruiting
    • Vasculopathy
    • Atorvastatin 80 Mg Oral Tablet
    • (no location specified)
    Apr 6, 2022

    Early Post Transplant Cardiac Allograft Vasculopathy

    Active, not recruiting
    • Cardiac Allograft Vasculopathy
      • Ottawa, Ontario, Canada
        University of Ottawa Heart Institute
      Feb 10, 2022

      Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

      Recruiting
      • Cardiac Allograft Vasculopathy
      • Los Angeles, California
        Ronald Regan UCLA Medical Center
      May 9, 2022

      Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

      Not yet recruiting
      • Transplant; Failure, Heart
      • +2 more
      • (no location specified)
      Nov 19, 2023

      Macular Polypoidal Choroidal Vasculopathy (PCV) Trial in Korea, Republic of (Brolucizumab 6mg)

      Not yet recruiting
      • Macular Polypoidal Choroidal Vasculopathy (PCV)
      • Brolucizumab 6mg
      • Busan, Korea, Republic of
      • +13 more
      Dec 19, 2022

      Polypoidal Choroidal Vasculopathy, Conbercept Trial in Beijing (Conbercept)

      Completed
      • Polypoidal Choroidal Vasculopathy
      • Conbercept
      • Beijing, China
        Peking Union Medical College Hospital
      Feb 7, 2022

      Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

      Recruiting
      • Polypoidal Choroidal Vasculopathy
      • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
      • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
      • Singapore, Singapore
      • +2 more
      Nov 14, 2022

      Cardiac Allograft Vasculopathy Trial in Brno, Prague (Alirocumab, Placebo)

      Recruiting
      • Cardiac Allograft Vasculopathy
      • Brno, Czechia
      • +1 more
      Apr 26, 2022

      Heart Transplant Trial in Omaha (Evolocumab (Repatha))

      Active, not recruiting
      • Heart Transplant
      • Evolocumab (Repatha)
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Dec 15, 2022

      Age-Related Macular Degeneration, Polypoid Choroidal Vasculopathy Trial (Episcleral Brachytherapy, Aflibercept Injection)

      Not yet recruiting
      • Age-Related Macular Degeneration
      • Polypoid Choroidal Vasculopathy
      • Episcleral Brachytherapy
      • Aflibercept Injection
      • (no location specified)
      Feb 21, 2022

      RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy Trial in Saint Louis, Philadelphia (Crizanlizumab)

      Active, not recruiting
      • RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
      • Saint Louis, Missouri
      • +1 more
      Jan 27, 2022

      Vasculopathy Trial in Stanford (alirocumab, )

      Enrolling by invitation
      • Vasculopathy
      • alirocumab
      • placebo
      • Stanford, California
        Stanford University
      May 22, 2022

      COVID-19 Trial in Baltimore (Crizanlizumab, 0.9% saline)

      Completed
      Has Results
      • COVID-19
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Nov 3, 2021

      Study of Heart Transplant Rejection

      Completed
      • Heart Transplantation
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 7, 2023

        Polypoidal Choroidal Vasculopathy Trial in Peking (non-interventional)

        Recruiting
        • Polypoidal Choroidal Vasculopathy
        • non-interventional
        • Peking, Beijing, China
          Peking Union Medical College Hospital
        Nov 28, 2022

        Donor-derived Cell-Free DNA asBiomarker in Cardiac Allograft

        Completed
        • Cardiac Allograft Vasculopathy
        • Donor-derived Cell Free DNA
        • Majadahonda, Madrid, Spain
          University Hospital Puerta de Hierro
        Sep 15, 2021

        Needs in Polypoidal Choroidal Vasculopathy (PCV)

        Recruiting
        • Polypoidal Choroidal Vasculopathy
        • Indocyanine Green Angiography
        • Singapore, Singapore
        • +2 more
        Sep 27, 2021

        Age Related Macular Degeneration, Polypoidal Choroidal Vasculopathy Trial in Singapore (Treat and Extend with Aflibercept 2mg,

        Completed
        Has Results
        • Age Related Macular Degeneration
        • Polypoidal Choroidal Vasculopathy
        • Treat and Extend with Aflibercept 2mg
        • Fixed Dosing with Aflibercept 2mg
        • Singapore, Singpore, Singapore
          Singapore National Eye Centre
        Aug 17, 2021